What is Alphanate?

ALPHANATE is a trusted treatment for patients with hemophilia A or von Willebrand disease (VWD) 1. Learn about ALPHANATE. ALPHANATE is a human plasma-derived factor complex that contains both factor VIII (FVIII) and von Willebrand factor (VWF).

How is Humate P supplied?

Humate-P is available as a sterile, lyophilized powder for intravenous administration following reconstitution. Each vial of Humate-P contains the labeled amount of VWF:RCo and FVIII activity expressed in International Units (IU).

Is Humate P A blood product?

As Humate P® is a plasma product there is a risk for transmission of infection. Humate P® should be given to a pregnant woman only if clearly needed. prescribed therapy.

Who manufactures advate?

Takeda has a variety of resources and programs to help you every step of the way with your treatment on ADVATE.

How is Alphanate used to treat hemophilia A?

ALPHANATE ® (antihemophilic factor/von Willebrand factor complex [human]) is indicated for: Control and prevention of bleeding episodes and perioperative management in adult and pediatric patients with factor VIII (FVIII) deficiency due to hemophilia A.

When to discontinue the use of Alphanate?

Anaphylaxis and severe hypersensitivity reactions are possible with ALPHANATE. Discontinue use of ALPHANATE if hypersensitivity symptoms occur, and initiate appropriate treatment. Development of procoagulant activity-neutralizing antibodies (inhibitors) has been detected in patients receiving FVIII-containing products.

When to take Alphanate for von Willebrand disease?

ALPHANATE ® (antihemophilic factor/von Willebrand factor complex [human]) is indicated for: Surgical and/or invasive procedures in adult and pediatric patients with von Willebrand disease (VWD) in whom desmopressin (DDAVP) is either ineffective or contraindicated. It is not indicated for patients with severe VWD (type 3) undergoing major surgery

What are the 10 steps to safety for Alphanate?

ALPHANATE is manufactured using 10 steps to safety with full traceability through the entire process from donor to patient.